| Trial ID: | L2407 |
| Source ID: | NCT05977465
|
| Associated Drug: |
Empagliflozin 25 Mg
|
| Title: |
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetic Neuropathy Peripheral
|
| Interventions: |
DRUG: Empagliflozin 25 MG
|
| Outcome Measures: |
Primary: Change in the electrophysiological assessment of sensory and motor nerve conduction of the lower limb extremities., The electrophysiological studies will be performed using Nihon Kohden Neuropack, six-channel apparatus (Nihon Kohden, Japan) using surface electrodes, for the two studied groups., change from baseline at three month|Change in HbA1c %, HbA1c % will be assayed in whole blood using an automated System (H.P.L.C model: G89051, Tosoh, USA), for the two studied groups., change from baseline at three months |
|
| Sponsor/Collaborators: |
Sponsor: Tanta University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-01-20
|
| Completion Date: |
2023-08-03
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-24
|
| Locations: |
Faculty of pharmacy, Tanta, 31111, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT05977465
|
